Aventis Pharma Limited
Aventis Pharma Limited, a prominent player in the pharmaceutical industry, is headquartered in Great Britain and operates extensively across Europe and Asia. Founded in the early 2000s, the company has established itself as a leader in innovative healthcare solutions, focusing on prescription medicines and specialty pharmaceuticals. With a diverse portfolio that includes treatments for chronic diseases, oncology, and rare conditions, Aventis Pharma is recognised for its commitment to research and development. The company’s unique approach to drug formulation and patient care has positioned it as a trusted name in the market. Notable achievements include significant advancements in biopharmaceuticals and a strong emphasis on sustainability in its operations. Aventis Pharma Limited continues to strive for excellence, making a meaningful impact on global health.
DitchCarbon Score
How does Aventis Pharma Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aventis Pharma Limited's score of 55 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Aventis Pharma Limited's reported carbon emissions
Aventis Pharma Limited, headquartered in Great Britain, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or the scope of their emissions (Scope 1, 2, or 3). However, the company is likely engaged in industry-standard climate commitments, which may include initiatives aimed at reducing environmental impact and enhancing sustainability practices. As the pharmaceutical sector increasingly focuses on climate action, Aventis Pharma Limited may be aligning its strategies with broader industry trends, although specific details on their commitments or initiatives are not provided.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Aventis Pharma Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
